Scientists have developed a new mRNA vaccine to treat pancreatic cancer that may extend patients' lifespans by 8 to 10 years.

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

Discover why pancreatic cancer's warning signs often go unnoticed, masquerading as everyday health issues, learn the crucial red flags that shouldn't be ignored ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

The symptoms of pancreatic cancer can be nonspecific, which means identifying the disease is often a challenge.

The American Cancer Society estimates that 67,400 Americans will be diagnosed with pancreatic cancer this year and nearly ...

Researchers have developed a simple blood test to detect pancreatic cancer before it spreads to other sites in the body. The ...

The discovery of a 'biomarker panel' could have a profound impact on the ability to identify patients at risk of developing ...

Personalized mRNA vaccines show promise as a pancreatic cancer treatment, according to a small, early stage trial published ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit offers insight into the new NCCN guidelines, discusses the new ...

An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and ...

Consultant General, Hepatobiliary Pancreatic and Liver Transplant Surgeon at Sunway Medical Centre Velocity (SMCV), Dr Johann ...